Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 2.0T | 2.0T | 1.6T | 1.4T |
Cost of revenue | 1.7T | 1.7T | 1.4T | 1.3T |
Gross profit | 209.2B | 211.5B | 154.4B | 150.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 136.5B | 120.0B | 106.9B | 89.5B |
Other operating expenses | 38.0B | 20.4B | 10.7B | 5.6B |
Operating income | 42.4B | 79.3B | 47.7B | 60.3B |
Non operating interest income | ||||
Income | 7.7B | 10.4B | 6.6B | 6.4B |
Expense | 5.2B | 3.2B | 2.8B | 2.1B |
Other income expense | — | — | — | — |
Pretax income | 47.1B | 88.0B | 52.3B | 64.5B |
Tax provision | 21.3B | 19.9B | 31.5B | 18.6B |
Net income | 25.8B | 68.1B | 20.8B | 46.0B |
Basic EPS | — | 315.2 | 78.6 | 210.2 |
Diluted EPS | — | 315.1 | 78.6 | 210.1 |
Basic average shares | — | 185.7M | 186.8M | 186.8M |
Diluted average shares | — | 185.7M | 186.8M | 186.8M |
EBITDA | 108.3B | 143.5B | 102.1B | 109.2B |
Net income from continuing op. | 47.1B | 88.0B | 52.3B | 64.5B |
Minority interests | -9.1B | -9.6B | -6.1B | -6.7B |
Preferred stock dividends | 0 | 0 | 0 | 0 |